Acute Migraine Clinical Trial
Official title:
A Clinical Investigation to Evaluate the Safety and Performance of the PBASE-system When Used in the Treatment of Acute Migraine Episodes of Moderate to Severe Intensity
To evaluate the performance and safety of the PBASE-system when used in the treatment of acute migraine episodes of moderate to severe intensity. The study will evaluate the effect of treatment on migraine pain and symptoms during an acute attack and also any long-term effect.
n/a
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04153409 -
A Proof of Concept Study of the Efficacy and Safety of Oral LAT8881 in Acute Migraine
|
Phase 2 | |
| Completed |
NCT02279082 -
DFN-02 Open Label Safety Study in Patients With Acute Migraine
|
Phase 3 | |
| Completed |
NCT04574362 -
Safety and Efficacy Trial of BHV3000 (Rimegepant) 75 mg for the Acute Treatment of Migraine
|
Phase 3 | |
| Completed |
NCT01973205 -
Efficacy and Safety of Acetaminophen and Aspirin Versus Placebo in the Acute Treatment of Migraine
|
Phase 3 | |
| Terminated |
NCT04089761 -
Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in Adolescents
|
N/A | |
| Completed |
NCT03631550 -
The RIME Study - Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine
|
N/A | |
| Completed |
NCT01267864 -
Valproate Versus Ketorolac Versus Metoclopramide
|
Phase 4 | |
| Completed |
NCT05371652 -
A Study to Learn About the Long-term Safety of Rimegepant for the Acute Treatment of Migraine in Chinese Participants
|
Phase 3 | |
| Completed |
NCT04218162 -
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine in Korean
|
Phase 3 | |
| Completed |
NCT01730326 -
Intravenous Dexketoprofen and Paracetamol in the Treatment of Headache Caused by Acute Migraine Attack
|
Phase 4 | |
| Completed |
NCT04408794 -
Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine
|
Phase 2/Phase 3 | |
| Completed |
NCT02745392 -
Safety and Efficacy of ZP-Zolmitriptan Intracutaneous Microneedle Systems for the Acute Treatment of Migraine
|
Phase 2/Phase 3 | |
| Completed |
NCT00894556 -
A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087)
|
Phase 3 | |
| Terminated |
NCT02185703 -
Chordate System S020 Acute Migraine Clinical Investigation
|
N/A | |
| Completed |
NCT01358279 -
Transcranial Direct Current Stimulation for Migraine Attack
|
N/A | |
| Not yet recruiting |
NCT01228552 -
The Efficacy and Safety of Intra-oral Topical Ketoprofen for the Treatment of Acute Migraine
|
Phase 3 | |
| Completed |
NCT02684409 -
Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute Migraine
|
Phase 1 | |
| Completed |
NCT02439320 -
Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:
|
Phase 3 | |
| Terminated |
NCT01112553 -
Treximet Migraine Brain Imaging Research Study
|
N/A | |
| Completed |
NCT01276977 -
Zolmitriptan Nasal Spray Versus Eletriptan in the Acute Treatment of Migraine
|
N/A |